Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis

被引：26

作者：

Kent, PD ^{[1
]}

Davis, JM ^{[1
]}

Davis, MDP ^{[1
]}

Matteson, EL ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN 55905 USA

来源：

ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 08期

关键词：

D O I：

10.1002/art.10348

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2257 / 2258

页数：2

共 8 条

[1]

*ARTHR ADV COMM, 2001, OP SESS FOOD DRUG AD

[2] Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen [J].

Chan, LS ;

Lapiere, JC ;

Chen, M ;

Traczyk, T ;

Mancini, AJ ;

Paller, AS ;

Woodley, DT ;

Marinkovich, MP .

ARCHIVES OF DERMATOLOGY, 1999, 135 (05) :569-573

[3]

Charles PJ, 2000, ARTHRITIS RHEUM, V43, P2383, DOI 10.1002/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO

[4]

2-D

[5] Review article: safety of infliximab in clinical trials [J].

Hanauer, SB .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 :16-22

[6] Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].

Keane, J ;

Gershon, S ;

Wise, RP ;

Mirabile-Levens, E ;

Kasznica, J ;

Schwieterman, WD ;

Siegel, JN ;

Braun, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104

[7]

SHAIBLE TF, 2000, CAN J GASTROENTER SC, V14, pC29

[8] Anti-tumor necrosis factor therapies [J].

Taylor, PC .

CURRENT OPINION IN RHEUMATOLOGY, 2001, 13 (03) :164-169

← 1 →